Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)
:RMD
RESEARCH TOOLSreports
Holding AU:RMD?
Track your performance easily
RMD Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$26.18 - AU$39.13
Previous CloseN/A
Volume1.29M
Average Volume (3M)855.63K
Market Cap
AU$56.23B
Enterprise ValueAU$52.23B
Total Cash (Recent Filing)$188.70M
Total Debt (Recent Filing)$269.99M
Price to Earnings (P/E)32.8
Beta0.85
Next Earnings
Jan 30, 2025EPS Estimate
0.37Last Dividend Ex-Date
Nov 06, 2024Dividend Yield0.81%
Share Statistics
EPS (TTM)1.14
Shares Outstanding1,467,957,400
10 Day Avg. Volume714,839
30 Day Avg. Volume855,631
Standard Deviation0.08
R-Squared0.05
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.69
Price to Cash Flow (P/CF)22.30
P/FCF Ratio22.30
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue11.08
Enterprise Value/Gross Profit19.67
Enterprise Value/Ebitda36.20
Forecast
1Y Price Target
AU$42.13Price Target Upside13.65% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh News
PremiumCompany Announcements
ResMed CFO Executes Stock Transaction Under Rule 10b5-1 Plan
PremiumCompany Announcements
Resmed Inc Officer Plans Further Sale of Common Shares
PremiumCompany Announcements
ResMed Chairman Emeritus Disposes Shares in Planned Transaction
PremiumCompany Announcements
ResMed Inc. Reports Change in Beneficial Ownership
PremiumCompany Announcements
Resmed Inc Adjusts Securities Amid Market DynamicsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.98% Public Companies and Individual Investors
RMD FAQ
What was Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price range in the past 12 months?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh lowest share price was AU$26.18 and its highest was AU$39.13 in the past 12 months.
What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s market cap?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s market cap is AU$56.23B.
When is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s upcoming earnings report date?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s upcoming earnings report date is Jan 30, 2025 which is in 11 days.
How were Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s earnings last quarter?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh released its earnings results on Oct 24, 2024. The company reported AU$0.354 earnings per share for the quarter, beating the consensus estimate of AU$0.331 by AU$0.022.
Is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh overvalued?
According to Wall Street analysts Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price is currently Undervalued.
Does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh pay dividends?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh pays a Annually dividend of AU$0.305 which represents an annual dividend yield of 0.81%. See more information on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh dividends here
What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s EPS estimate?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s EPS estimate is 0.37.
How many shares outstanding does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh have?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has 1,467,957,400 shares outstanding.
What happened to Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price movement after its last earnings report?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh reported an EPS of AU$0.354 in its last earnings report, beating expectations of AU$0.331. Following the earnings report the stock price went up 5.937%.
Which hedge fund is a major shareholder of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh?
Currently, no hedge funds are holding shares in AU:RMD
---
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$42.13 (13.65% Upside)
AU$42.13 (13.65% Upside)
Blogger Sentiment
Bullish
AU:RMD Sentiment 70%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
48.32%
12-Months-Change
Fundamentals
Return on Equity
23.97%
Trailing 12-Months
Asset Growth
-0.32%
Trailing 12-Months
Company Description
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
---
RMD Revenue Breakdown
88.21% Sleep and Respiratory Care
11.79% Software as a Service
---
RMD Stock 12 Month Forecast
Average Price Target
AU$42.13
▲(13.65% Upside)
Technical Analysis
Sonic Healthcare Limited
―
Edwards Lifesciences
―
Dexcom
―
Idexx Laboratories
―
Resmed
―
Baxter International
―
Best Analysts Covering RMD
1 Year
1 Year Success Rate
8/11 ratings generated profit
1 Year Average Return
+16.89%
reiterated a buy rating 3 months ago
Copying Shane Storey's trades and holding each position for 1 Year would result in 72.73% of your transactions generating a profit, with an average return of +16.89% per trade.
---